Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Insulet Corporation
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the userÔÇÖs personalized insulin-delivery instructions and wirelessly monitors the PodÔÇÖs operation.

Number of employees : 1 900 people.
Sales per Business
20192020Delta
United States Omnipod420.4056.9%526.9058.3% +25.33%
International Omnipod253.1034.3%308.0034.1% +21.69%
Drug Delivery64.708.8%69.507.7% +7.42%
USD in Million
Sales per region
20192020Delta
United States485.1065.7%596.4065.9% +22.94%
International253.1034.3%308.0034.1% +21.69%
USD in Million
Managers
Name Title Age Since
Shacey Petrovic President, Chief Executive Officer & Director 46 2019
Wayde McMillan Chief Financial Officer, Treasurer & Executive VP 50 2019
Trang Ly Senior Vice President & Medical Director - 2018
Charles Alpuche Chief Operations Officer & Executive VP 60 2019
Michael Spears Senior VP-Quality, Regulatory Affairs & Compliance 55 2017
Sally W. Crawford Independent Director 66 2013
Timothy Scannell Independent Chairman 55 2019
Jessica Hopfield, Dr. Independent Director 55 2018
David A. Lemoine Independent Director 72 2016
Michael Minogue Independent Director 53 2017
Members of the board
Name Title Age Since
Timothy Scannell Independent Chairman 55 2019
Sally W. Crawford Independent Director 66 2013
Shacey Petrovic President, Chief Executive Officer & Director 46 2019
Jessica Hopfield, Dr. Independent Director 55 2018
David A. Lemoine Independent Director 72 2016
Michael Minogue Independent Director 53 2017
Corinne H. Nevinny Independent Director 60 2019
James R. Hollingshead, Dr. Independent Director 57 2019
Wayne A. I. Frederick, Dr. Independent Director 48 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 68,873,869 68,595,399 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Fidelity Management & Research Co. LLC 9,564,414 13.9%
Capital Research & Management Co. (World Investors) 7,147,234 10.4%
Capital Research & Management Co. (Global Investors) 6,887,770 10.0%
The Vanguard Group, Inc. 5,750,415 8.35%
Park Avenue Institutional Advisers LLC 4,000,000 5.81%
Wellington Management Co. LLP 2,921,116 4.24%
Capital Research & Management Co. 1,902,680 2.76%
Federated Equity Management Company of Pennsylvania 1,670,500 2.43%
Viking Global Investors LP 1,595,288 2.32%
PRIMECAP Management Co. 1,468,080 2.13%
Company contact information
Insulet Corp.
100 Nagog Park
Acton, MA 01720

Phone : +1.978.600.7000
Fax : +1.978.600.0120
Web : http://www.insulet.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Insulet Corporation
Sector Other Medical Equipment, Supplies & Distribution